+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Attention-deficit/Hyperactivity Disorder (ADHD) Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5327633
  • Report
  • August 2020
  • Region: Global
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Celltech Group Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Purdue Pharma L.P.
  • Shire Plc
  • MORE
Attention deficit hyperactivity disorder (ADHD) is a neural disorder. The disorder is characterized by impulsiveness, hyperactivity, and attention difficulty. Treatment of ADHD involves a combination of counseling, medications, and lifestyle changes. ADHD is the most commonly diagnosed mental disorder in adults and children with the exact cause being unidentified in the majority of cases. Researchers at the National Institute of Mental Health (NIMH) suggest the factors affecting mental illness include heredity, brain injuries, low birth weight, drugs use during pregnancy and exposure to environmental toxins such, as lead at young age. The currently available treatments, such as medication, counseling, lifestyle changes or a combination of these treatments helps in reducing symptoms with improved functioning of patient.

Restraints of the Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market

Major factors hampering the growth of the attention-deficit hyperactivity disorder (ADHD) therapeutics market during the forecast period constitutes of side effects, and drug abuse risks.

Key features of the study:
  • This report provides in-depth analysis of the global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Amedra Pharmaceuticals LLC, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Noven Pharmaceuticals, Inc., RespireRx Pharmaceuticals Inc., Otsuka Pharmaceutical Co., Ltd., American BriVision (Holding) Corporation, Novartis Pharmaceuticals Corporation, Shire, GlaxoSmithKline, Celltech Group Ltd., and Purdue Pharma L.P.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation

Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Drug Type:
  • Stimulants
  • Amphetamine
  • Methylphenidate
  • Dextroamphetamine
  • Dexmethylphenidate
  • Lisdexamfetamine Dimesylate
  • Non-stimulants
  • Atomoxetine
  • Bupropion
  • Guanfacine
  • Clonidine
Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Age Group:
  • Pediatric and Adolescent
  • Adults
Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Distribution Channel:
  • Specialty Clinics
  • Hospital Pharmacies
  • Retail Pharmacies
  • e-Commerce
Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Geography:
  • North America
By Country:
  • U.S.
  • Canada
  • Europe
By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
o Middle East:

By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Amedra Pharmaceuticals LLC*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Eli Lilly and Company
  • Janssen Pharmaceuticals, Inc.
  • Noven Pharmaceuticals, Inc.
  • RespireRx Pharmaceuticals Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • American BriVision (Holding) Corporation
  • Novartis Pharmaceuticals Corporation
  • Shire Plc
  • GlaxoSmithKline
  • Celltech Group Ltd.
  • Purdue Pharma L.P.
“*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Celltech Group Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Purdue Pharma L.P.
  • Shire Plc
  • MORE
1. Research Objective and Assumption
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug Type
  • Market Snippet, By Age Group
  • Market Snippet, By Distribution Channel
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • COVID-19 Impact Analysis
4. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Drug Type, 2019 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • Stimulants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
  • Amphetamine
  • Methylphenidate
  • Dextroamphetamine
  • Dexmethylphenidate
  • Lisdexamfetamine Dimesylate
  • Non-stimulants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
  • Atomoxetine
  • Bupropion
  • Guanfacine
  • Clonidine
5. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Age Group, 2019 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • Pediatric and Adolescent
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
6. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Distribution Channel, 2019 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • e-Commerce
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
7. Global Attention-deficit Hyperactivity Disorder (ADHD) Therapeutics Market, By Regions, 2019 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • U.S.
  • Canada
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa
8. Competitive Landscape
  • Company Profiles
  • Amedra Pharmaceuticals LLC
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Eli Lilly and Company
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Janssen Pharmaceuticals, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Noven Pharmaceuticals, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • RespireRx Pharmaceuticals Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Otsuka Pharmaceutical Co., Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • American BriVision (Holding) Corporation
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Novartis Pharmaceuticals Corporation
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Shire Plc
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • GlaxoSmithKline
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Celltech Group Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Purdue Pharma L.P.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
9. Section
  • References
  • Research Methodology
  • About us and Sales Contact
Note: Product cover images may vary from those shown
  • Amedra Pharmaceuticals LLC
  • Eli Lilly and Company
  • Janssen Pharmaceuticals, Inc.
  • Noven Pharmaceuticals, Inc.
  • RespireRx Pharmaceuticals Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • American BriVision (Holding) Corporation
  • Novartis Pharmaceuticals Corporation
  • Shire Plc
  • GlaxoSmithKline
  • Celltech Group Ltd.
  • Purdue Pharma L.P.
Note: Product cover images may vary from those shown
Adroll
adroll